(Q37872569)

24 August 2017

title

Parameters of inflammation and infection in a community based case-control study of coronary heart disease (English)

1 reference

24 August 2017

0 references

De Backer J

1

1 reference

24 August 2017

Mak R

2

1 reference

24 August 2017

De Bacquer D

3

1 reference

24 August 2017

Van Renterghem L

4

1 reference

24 August 2017

Verbraekel E

5

1 reference

24 August 2017

Kornitzer M

6

1 reference

24 August 2017

De Backer G

7

1 reference

24 August 2017

publication date

1 February 2002

1 reference

24 August 2017

1 reference

24 August 2017

volume

160

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

457-463

1 reference

C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Fibrinogen as a risk factor for stroke and myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Elevated C-reactive protein levels in overweight and obese adults

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

inferred from DOI database lookup

7 January 2021

based on heuristic

C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Cytomegalovirus and atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Relation of Helicobacter pylori infection and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Infection With Helicobacter pylori Is Not a Major Independent Risk Factor for Stable Coronary Heart Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

An international association between Helicobacter pylori infection and gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

The first international standard for serum amyloid A protein (SAA). Evaluation in an international collaborative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

The leukocyte count as a predictor of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Helicobacter pylori and the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Helicobacter pylori infection and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900602-5

10.1016/S0021-9150(01)00602-5

7 January 2021

Identifiers

DOI

1 reference

24 August 2017

1 reference